Click for best price
Cold Flu Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 37850 million
|
Forecast Market size by 2030 |
US$ 56380 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
110 Pages |
The global Cold and Flu Drugs market was valued at US$ 37850 million in 2023 and is projected to reach US$ 56380 million by 2030, at a CAGR of 5.9% during the forecast period.
The USA market for Global Cold and Flu Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cold and Flu Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cold and Flu Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Cold and Flu Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cold and Flu Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cold and Flu Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Cold and Flu Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cold and Flu Drugs market presents opportunities for various stakeholders, including OTC, Rx. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cold and Flu Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The Cough and Cold Remedies Market is driven by the recurring nature of respiratory ailments and seasonal illnesses, such as coughs and colds, which create a consistent demand for over-the-counter remedies. Cough and cold remedies, including cough syrups, decongestants, and throat lozenges, provide individuals with relief from common symptoms and discomfort associated with these ailments. As consumers prioritize self-care and symptom management, the market for these remedies continues to expand. The advent of innovative formulations and delivery methods further fuels market growth. However, a significant challenge for this market is the need to address regulatory and safety concerns surrounding certain ingredients, ensuring that remedies are effective and safe for users. Overcoming the evolving landscape of cold and flu viruses and the need to tailor products to address specific symptoms pose ongoing challenges. Additionally, the market faces competition from alternative therapies, natural remedies, and preventive measures. Striking a balance between providing accessible and reliable remedies for symptom relief while navigating evolving consumer preferences and safety considerations is crucial for the continued growth of the Cough and Cold Remedies Market.
Key Features:
The research report on the Cold and Flu Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cold and Flu Drugs market.
Market Overview: The report provides a comprehensive overview of the Cold and Flu Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antihistamines, Expectorants), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cold and Flu Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cold and Flu Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cold and Flu Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cold and Flu Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cold and Flu Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cold and Flu Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cold and Flu Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cold and Flu Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cold and Flu Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
Market segment by Application
Global Cold and Flu Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Reckitt Benckiser Group
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Bayer
- AstraZeneca
- Sun Pharmaceutical Industries
- Pfizer
- Prestige Brands Holdings
- Procter & Gamble
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cold and Flu Drugs, market overview.
Chapter 2: Global Cold and Flu Drugs market size in revenue.
Chapter 3: Detailed analysis of Cold and Flu Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cold and Flu Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cold and Flu Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 37850 million
|
| Forecast Market size by 2030 |
US$ 56380 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cold and Flu Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cold and Flu Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cold and Flu Drugs Overall Market Size
2.1 Global Cold and Flu Drugs Market Size: 2023 VS 2030
2.2 Global Cold and Flu Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cold and Flu Drugs Players in Global Market
3.2 Top Global Cold and Flu Drugs Companies Ranked by Revenue
3.3 Global Cold and Flu Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cold and Flu Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cold and Flu Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cold and Flu Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cold and Flu Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cold and Flu Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cold and Flu Drugs Market Size Markets, 2023 & 2030
4.1.2 Antihistamines
4.1.3 Expectorants
4.1.4 Bronchodilators
4.1.5 Decongestants
4.1.6 Antibiotics
4.1.7 Others
4.2 By Type - Global Cold and Flu Drugs Revenue & Forecasts
4.2.1 By Type - Global Cold and Flu Drugs Revenue, 2019-2024
4.2.2 By Type - Global Cold and Flu Drugs Revenue, 2025-2030
4.2.3 By Type - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cold and Flu Drugs Market Size, 2023 & 2030
5.1.2 OTC
5.1.3 Rx
5.2 By Application - Global Cold and Flu Drugs Revenue & Forecasts
5.2.1 By Application - Global Cold and Flu Drugs Revenue, 2019-2024
5.2.2 By Application - Global Cold and Flu Drugs Revenue, 2025-2030
5.2.3 By Application - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cold and Flu Drugs Market Size, 2023 & 2030
6.2 By Region - Global Cold and Flu Drugs Revenue & Forecasts
6.2.1 By Region - Global Cold and Flu Drugs Revenue, 2019-2024
6.2.2 By Region - Global Cold and Flu Drugs Revenue, 2025-2030
6.2.3 By Region - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cold and Flu Drugs Revenue, 2019-2030
6.3.2 US Cold and Flu Drugs Market Size, 2019-2030
6.3.3 Canada Cold and Flu Drugs Market Size, 2019-2030
6.3.4 Mexico Cold and Flu Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cold and Flu Drugs Revenue, 2019-2030
6.4.2 Germany Cold and Flu Drugs Market Size, 2019-2030
6.4.3 France Cold and Flu Drugs Market Size, 2019-2030
6.4.4 U.K. Cold and Flu Drugs Market Size, 2019-2030
6.4.5 Italy Cold and Flu Drugs Market Size, 2019-2030
6.4.6 Russia Cold and Flu Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Cold and Flu Drugs Market Size, 2019-2030
6.4.8 Benelux Cold and Flu Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cold and Flu Drugs Revenue, 2019-2030
6.5.2 China Cold and Flu Drugs Market Size, 2019-2030
6.5.3 Japan Cold and Flu Drugs Market Size, 2019-2030
6.5.4 South Korea Cold and Flu Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Cold and Flu Drugs Market Size, 2019-2030
6.5.6 India Cold and Flu Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cold and Flu Drugs Revenue, 2019-2030
6.6.2 Brazil Cold and Flu Drugs Market Size, 2019-2030
6.6.3 Argentina Cold and Flu Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cold and Flu Drugs Revenue, 2019-2030
6.7.2 Turkey Cold and Flu Drugs Market Size, 2019-2030
6.7.3 Israel Cold and Flu Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Cold and Flu Drugs Market Size, 2019-2030
6.7.5 UAE Cold and Flu Drugs Market Size, 2019-2030
7 Cold and Flu Drugs Companies Profiles
7.1 Reckitt Benckiser Group
7.1.1 Reckitt Benckiser Group Company Summary
7.1.2 Reckitt Benckiser Group Business Overview
7.1.3 Reckitt Benckiser Group Cold and Flu Drugs Major Product Offerings
7.1.4 Reckitt Benckiser Group Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.1.5 Reckitt Benckiser Group Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Cold and Flu Drugs Major Product Offerings
7.2.4 Johnson & Johnson Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Cold and Flu Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Cold and Flu Drugs Major Product Offerings
7.4.4 Novartis Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cold and Flu Drugs Major Product Offerings
7.5.4 Bayer Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.5.5 Bayer Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Cold and Flu Drugs Major Product Offerings
7.6.4 AstraZeneca Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Cold and Flu Drugs Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Cold and Flu Drugs Major Product Offerings
7.8.4 Pfizer Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Prestige Brands Holdings
7.9.1 Prestige Brands Holdings Company Summary
7.9.2 Prestige Brands Holdings Business Overview
7.9.3 Prestige Brands Holdings Cold and Flu Drugs Major Product Offerings
7.9.4 Prestige Brands Holdings Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.9.5 Prestige Brands Holdings Key News & Latest Developments
7.10 Procter & Gamble
7.10.1 Procter & Gamble Company Summary
7.10.2 Procter & Gamble Business Overview
7.10.3 Procter & Gamble Cold and Flu Drugs Major Product Offerings
7.10.4 Procter & Gamble Cold and Flu Drugs Revenue in Global Market (2019-2024)
7.10.5 Procter & Gamble Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cold and Flu Drugs Market Opportunities & Trends in Global Market
Table 2. Cold and Flu Drugs Market Drivers in Global Market
Table 3. Cold and Flu Drugs Market Restraints in Global Market
Table 4. Key Players of Cold and Flu Drugs in Global Market
Table 5. Top Cold and Flu Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cold and Flu Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cold and Flu Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cold and Flu Drugs Product Type
Table 9. List of Global Tier 1 Cold and Flu Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cold and Flu Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cold and Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cold and Flu Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cold and Flu Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cold and Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cold and Flu Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cold and Flu Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cold and Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cold and Flu Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cold and Flu Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cold and Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cold and Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cold and Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cold and Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cold and Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cold and Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cold and Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cold and Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cold and Flu Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cold and Flu Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Reckitt Benckiser Group Company Summary
Table 31. Reckitt Benckiser Group Cold and Flu Drugs Product Offerings
Table 32. Reckitt Benckiser Group Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Reckitt Benckiser Group Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Cold and Flu Drugs Product Offerings
Table 36. Johnson & Johnson Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. GlaxoSmithKline Company Summary
Table 39. GlaxoSmithKline Cold and Flu Drugs Product Offerings
Table 40. GlaxoSmithKline Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. GlaxoSmithKline Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Cold and Flu Drugs Product Offerings
Table 44. Novartis Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Novartis Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Cold and Flu Drugs Product Offerings
Table 48. Bayer Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Bayer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Cold and Flu Drugs Product Offerings
Table 52. AstraZeneca Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Sun Pharmaceutical Industries Company Summary
Table 55. Sun Pharmaceutical Industries Cold and Flu Drugs Product Offerings
Table 56. Sun Pharmaceutical Industries Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Sun Pharmaceutical Industries Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Cold and Flu Drugs Product Offerings
Table 60. Pfizer Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Prestige Brands Holdings Company Summary
Table 63. Prestige Brands Holdings Cold and Flu Drugs Product Offerings
Table 64. Prestige Brands Holdings Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Prestige Brands Holdings Key News & Latest Developments
Table 66. Procter & Gamble Company Summary
Table 67. Procter & Gamble Cold and Flu Drugs Product Offerings
Table 68. Procter & Gamble Cold and Flu Drugs Revenue (US$, Mn) & (2019-2024)
Table 69. Procter & Gamble Key News & Latest Developments
List of Figures
Figure 1. Cold and Flu Drugs Segment by Type in 2023
Figure 2. Cold and Flu Drugs Segment by Application in 2023
Figure 3. Global Cold and Flu Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cold and Flu Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cold and Flu Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cold and Flu Drugs Revenue in 2023
Figure 8. By Type - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cold and Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cold and Flu Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 16. US Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 28. China Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cold and Flu Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cold and Flu Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Reckitt Benckiser Group Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Johnson & Johnson Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. GlaxoSmithKline Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Novartis Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bayer Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. AstraZeneca Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Sun Pharmaceutical Industries Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Pfizer Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Prestige Brands Holdings Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Procter & Gamble Cold and Flu Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
